Clinical Trial Update: Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating continuing bevacizumab after first progression in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Asan Medical Center | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED